Harrison W Farber

9PUBLICATIONS
31CO-AUTHORS
Cell physiologyRespiratory diseasesPharmacogenomicsTraditional, complementary and integrative medicine not elsewhere classifiedMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 01, 2025
Pulmonary Arterial Wedge Oxygen Saturation: Does It Confirm Wedge Position in Patients With Pulmonary Hypertension?

Ambalavanan Arunachalam, Fernando Martinez Guasch, Tanvi Nayak

|Sep 06, 2025
Real-World Adherence and Persistence of Upfront Therapy in Patients with Pulmonary Arterial Hypertension in the United States.

Teresa De Marco, Carly J Paoli, Nicole S Croteau

|Aug 05, 2025
Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity.

Harrison W Farber, Murali M Chakinala, Anna R Hemnes

|Apr 21, 2025
A Prospective Analysis of Vasoreactivity and Mortality in WHO Group 3 Pulmonary Hypertension.

Daniel J Strick, Carl Tanba, Meredith A Kaplan

|Apr 16, 2024
Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States.

Harrison W Farber, Hayley D Germack, Nicole S Croteau

|Aug 11, 2023
The PH-ILD Detection tool: External validation and use in patients with ILD.

Raj Parikh, David M O'Sullivan, Harrison W Farber

Pageof 2

Frequent Collaborators

2 joint publications

Raj Parikh

2 joint publications

Murali M Chakinala

2 joint publications

Nicole S Croteau

1 joint publications

Robert P Frantz